Computational method predicts new uses for existing medici – 4
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Biotech or pharmaceutical companies might not pursue existing drugs for other treatments if the drugs are already off-patent, meaning low-cost generics exists; or the treatment might be for a so-called orphan disease that has relatively few patients.
Butte: Those are businesses decisions more than scientific ones.
Narrator: So Dr. Atul Butte, an NIH grantee at Stanford University has been using computers to search drug-disease combinations in hopes of saving time and money. He adds:
Butte: If we didn’t find these uses for these drugs I would argue that nobody would ever find these uses for these drugs.
Narrator: For more information on this computational study and this kind of research, visit www.nigms.nih.gov. Health Matters is produced by the NIH, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.